3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4 Argatroban Intermediate Factory 98.0%

ʻO ka wehewehe pōkole:

Inoa Kemika: 3-Methyl-8-Quinolinesulphonyl Chloride

CAS: 74863-82-4

ʻAno: ʻO ka pauka kristal keʻokeʻo

Maʻemaʻe: >98.0% (HPLC)

ʻO ka waena o Argatroban (CAS 74863-84-6), he Synthetic Thrombin Inhibitor.Antithrombotic

Kūlana Kiʻekiʻe, Hana Kūʻai

Inquiry: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia 3-Methyl-8-Quinolinesulphonyl Chloride
Nā huaʻōlelo like 3-Methylquinoline-8-Sulfonyl Chloride
Helu CAS 74863-82-4
Helu CAT RF-PI269
Kūlana Kūʻai Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona
ʻĀpana Molekala C10H8ClNO2S
Kaumaha Molecular 241.69
ʻO ka mānoanoa 1.4±0.1 g/cm3
Hōʻike Hōʻike 1.63
Ka hoʻoheheʻe Hiki ke hoʻoheheʻe ʻia i loko o Chloroform
Kūlana Hoʻouna Hoʻouna ʻia ma lalo o ka wela ambient
Brand ʻO Ruifu Chemical

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Pauda Crystalline Keʻokeʻo
Maʻemaʻe / Kaʻina Hanana >98.0% (HPLC)
Lae hehee 162.0~163.0 ℃
Nalo ma ka maloo <0.50%
3-Methylquinoline-8-Sulfonic Acid <1.00%
Huina paumaele <2.00%
Infrared Spectrum Kūlike i ka hoʻolālā
NMR Kūlike i ka hoʻolālā
Kūlana hoʻāʻo ʻOihana Kūlana
Hoʻohana Kūwaena o Argatroban (CAS 74863-84-6)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Pale mai ka māmā a me ka makū

Pono:

1

FAQ:

Noi:

ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui a me ka mea hoʻolako o 3-Methyl-8-Quinolinesulphonyl Chloride (CAS: 74863-82-4) me ke ʻano kiʻekiʻe, hoʻohana nui ʻia i ka synthesis organik, synthesis o nā intermediates pharmaceutical a me Active Pharmaceutical Ingredient (API) synthesis.ʻO iahe mea waena maʻamau i ka synthesis o Argatroban (CAS: 74863-84-6) a i ʻole Argatroban Monohydrate (CAS 141396-28-3).

ʻO Argatroban (CAS: 74863-84-6) kahi anticoagulant kahi mole liʻiliʻi liʻiliʻi pololei thrombin inhibitor.I ka makahiki 2000, ua laikini ʻia ka argatroban e ka Food and Drug Administration (FDA) no ka prophylaxis a i ʻole ka mālama ʻana i ka thrombosis i nā maʻi me ka thrombocytopenia (HIT).I ka makahiki 2002, ua ʻae ʻia no ka hoʻohana ʻana i ka wā o ka hoʻoponopono coronary percutaneous i nā poʻe maʻi i loaʻa iā HIT a i ʻole ka pilikia no ka hoʻomohala ʻana.Ma 2012, ua ʻae ʻia e ka MHRA ma UK no ka anticoagulation i nā maʻi me ka heparin-induced thrombocytopenia Type II (HIT) e koi ana i ka antithrombotic therapy parenteral.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou